Standard BioTools (LAB) Stock Price, News, Quotes-Moomoo

$Standard BioTools (LAB.US)$ Standard BioTools Purchases the Carterra® Lsa-Xt System to Accelerate Data Delivery and Provide Greater Validation to Somascan Customers

Trytosaveabit

May 8 15:23

Decent

$Standard BioTools (LAB.US)$ Revenue was $46 million, up 81% year-over-year, with impact of SomaScan
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.

Trytosaveabit

Apr 8 07:03

Update

$Standard BioTools (LAB.US)$ Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

LAB Standard BioTools

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target